4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-049360
Chief Business Officer sold 1,266 shares at $10.41 ($13,179)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan Chief Business Officer | 2023-09-12 | Sale 10b5-1 | −1,266 | $10.41 | $13,179 | 61,866 | D |
| Open-market sales · 1,266 sh · avg $10.41 · $13,179 | |||||||
Loading xslF345X05/doc4.xml…